In addition, recent epidemiological and population-based studies have linked elevated plasma ApoC-III levels with hypertriglyceridemia, risk of cardiovascular disease and metabolic syndrome3–10, 18. The gene discussed is APOC3; the disease is hypertriglyceridemia.